These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 30235216)

  • 1. Epidemiological and economic burden of potentially HPV-related cancers in France.
    Abramowitz L; Lacau Saint Guily J; Moyal-Barracco M; Bergeron C; Borne H; Dahlab A; Bresse X; Uhart M; Cancalon C; Catella L; Bénard S
    PLoS One; 2018; 13(9):e0202564. PubMed ID: 30235216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C
    PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic burden of HPV-related cancers in France.
    Borget I; Abramowitz L; Mathevet P
    Vaccine; 2011 Jul; 29(32):5245-9. PubMed ID: 21616117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The healthcare costs of treating human papillomavirus-related cancers in Norway.
    Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
    BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
    Chaturvedi AK
    J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic burden of non-cervical cancers attributable to human papillomavirus: a European scoping review.
    Préaud E; Largeron N
    J Med Econ; 2013; 16(6):763-76. PubMed ID: 23565814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Nelson RA; Lai LL
    Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of the epidemiological impact and disease cost-savings of HPV vaccines in France.
    Bresse X; Adam M; Largeron N; Roze S; Marty R
    Hum Vaccin Immunother; 2013 Apr; 9(4):823-33. PubMed ID: 23563511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic burden of human papillomavirus infection-associated diseases in the Republic of Korea, 2002-2015.
    Ki M; Choi HY; Han M; Oh JK
    Vaccine; 2018 Jul; 36(31):4633-4640. PubMed ID: 29961603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and evidence synthesis of non-cervical human papillomavirus-related disease health system costs and quality of life estimates.
    Ong KJ; Checchi M; Burns L; Pavitt C; Postma MJ; Jit M
    Sex Transm Infect; 2019 Feb; 95(1):28-35. PubMed ID: 30674687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of human papillomaviruses in cancers of different human organ sites.
    Shukla S; Bharti AC; Mahata S; Hussain S; Kumar R; Hedau S; Das BC
    Indian J Med Res; 2009 Sep; 130(3):222-33. PubMed ID: 19901431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental healthcare resource utilization and costs for patients with cervical, vaginal, vulvar, anal, and oropharyngeal cancer in the United States.
    Prabhu V; Kathe N; Saxena K; Walia A; Markan R; Myers E; Einstein M
    Curr Med Res Opin; 2021 Sep; 37(9):1599-1607. PubMed ID: 34018457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presumed previous human papillomavirus (HPV) related gynecological cancer in women diagnosed with anal cancer in the province of Ontario.
    Jiménez W; Paszat L; Kupets R; Wilton A; Tinmouth J
    Gynecol Oncol; 2009 Sep; 114(3):395-8. PubMed ID: 19501390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
    Louchini R; Goggin P; Steben M
    Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of Disease of Human Papillomavirus (HPV): Hospitalizations in the Marche and Veneto Regions. An observational study.
    Mennini FS; Fabiano G; Marcellusi A; Sciattella P; Saia M; Cocchio S; Baldo V
    Clin Drug Investig; 2018 Feb; 38(2):173-180. PubMed ID: 29081028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [HPV DNA genotyping: A study of anogenital, head and neck and skin cancers in a population from west Algerian. HPV detection in different cancers from an Algerian population].
    Nahet A; Boublenza L; Hassaine H; Masdoua N; Prétet JL; Belglaiaa E; Mougin C
    Bull Cancer; 2016 May; 103(5):455-60. PubMed ID: 27085765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvar and vaginal cancers and dysplasia in France--an analysis of the hospital medical information system (PMSI) database.
    Rémy V; Mathevet P; Vainchtock A
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec; 147(2):210-4. PubMed ID: 19735968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
    Pitisuttithum P; Velicer C; Luxembourg A
    Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France.
    Riethmuller D; Jacquard AC; Lacau St Guily J; Aubin F; Carcopino X; Pradat P; Dahlab A; Prétet JL
    BMC Public Health; 2015 May; 15():453. PubMed ID: 25934423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.